Comparing the effectiveness of biological disease-modifying antirheumatic drugs using real-world data-Reference-Cited by-同舟云学术

Comparing the effectiveness of biological disease-modifying antirheumatic drugs using real-world data

Published:2018-08-02 Issue:1 Volume:29 Page:87-97
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Takabayashi Katsuhiko¹²,Ando Fumihiko³,Suzuki Takahiro²

Affiliation:

1. Sanwa Hospital, Chiba, Japan;

2. Department of Medical Informatics and Management, Chiba University Hospital, Chiba, Japan;

3. MISANE Corporation, Dallas, TX, USA

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14397595.2018.1447264

Reference45 articles.

1. Are All Biologics the Same? Optimal Treatment Strategies for Patients With Early Rheumatoid Arthritis

2. Comparative effectiveness of biologics for the management of rheumatoid arthritis: systematic review and network meta-analysis

3. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study

4. Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis

5. Ochiai M, Sato E, Tanaka E, Inoue E, Nakajima A, Momohara S, et al. Discontinuation of biologics in patients with rheumatoid arthritis after achieving low-activity disease status. Arthritis Rheumatol. 2014;66(10):S213.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide;Reumatología Clínica;2024-07

2. Seasonal exacerbation of rheumatoid arthritis detected by big claims data analysis: A retrospective population study;Modern Rheumatology;2022-02-15

3. Patterns of biologic and targeted-synthetic disease-modifying antirheumatic drug use in rheumatoid arthritis in Australia;Rheumatology;2022-01-30

4. Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world study;Modern Rheumatology;2021-12-15

5. Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study;Rheumatology and Therapy;2021-08-26